Background Remdesivir is considered to be a specific drug for treating coronavirus disease
2019. This systematic review aims to evaluate the clinical efficacy and risk of remdesivir …

Introduction Remdesivir is a nucleoside analog that inhibits viral RNA replication by blocking
RNA-dependent RNA polymerase. First developed and tested during the Ebola epidemic …

Background Remdesivir, an antiviral agent able to reduce inflammatory cascade
accompanying severe, life-threatening pneumonia, became the first drug approved by the …

Purpose To evaluate the safety and efficacy of favipiravir, which is prescribed for the
treatment of patients with mild-to-moderate coronavirus disease 2019 (COVID-19) in India …

(1) Background: Favipiravir (FVP) is a new antiviral drug used to treat COVID-19. It has been
authorized to be used in the kingdom of Saudi Arabia in the treatment of COVID-19. The …

Remdesivir termasuk dalam tatalaksana coronavirus disease 2019 (Covid-19). Efek
farmakologik remdesivir juga berdampak terhadap perbaikan biomarker inflamasi …

Background The study aimed to analyze the demographic, comorbidities, biomarkers,
pharmacotherapy, and ICU-stay with the mortality outcome of COVID-19 patients admitted in …

COVID-19 patients in critical conditions are hospitalized and treated with various protocols
including antiviral drugs, which have been updated repeatedly. This study was aimed to …

Background: The first recognition of a cluster of COVID-19 patients in China in late 2019,
has become a major concern due to its greater transmissibility and vulnerability of the …

Background Remdesivir was considered to be a specific drug for Corona Virus Disease
2019. This systematic review aims to evaluate remdesivir monotherapy and combination …